BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...

LabCorp on Tuesday announced the launch of the first testing method to simultaneously detect for COVID-19, influenza A / B, and respiratory syncytial virus (RSV) ahead of flu season. CDC tells states: ...

Access to rapidly developing diagnostic technology such as blood-based biomarkers for early detection and subsequent ...

Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

LabCorp, a medical diagnostics company in Burlington, N.C., detected “suspicious activities” on its computer network over the July 14 weekend that may have compromised the health records of millions ...

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors PR Newswire BURLINGTON, N.C., Feb. 24, 2025 Labcorp® Plasma ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million for ...